Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01237236 |
| Title | A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma. |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | NLD | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana Farber Cancer Institute DFCI | Boston | Massachusetts | 02215 | United States | Details | |
| University of Michigan Comprehensive Cancer Center SC | Ann Arbor | Michigan | +1 48109 0944 | United States | Details | |
| Memorial Sloan Kettering MSKCC (2) | New York | New York | 10017 | United States | Details | |
| Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2) | Nashville | Tennessee | 37203 | United States | Details | |
| Novartis Investigative Site | Lyon Cedex | 69373 | France | Details | ||
| Novartis Investigative Site | Villejuif Cedex | 94805 | France | Details | ||
| Novartis Investigative Site | Utrecht | 3584CX | Netherlands | Details |